Live attenuated rotavirus vaccine for oral administration

Details for Australian Patent Application No. 2006215761 (hide)

Owner GlaxoSmithKline Biologicals S.A.

Inventors Vande Velde, Vincent

Agent Shelston IP

Pub. Number AU-B-2006215761

PCT Pub. Number WO2006/087205

Priority 0503337.8 17.02.05 GB

Filing date 15 February 2006

Wipo publication date 24 August 2006

Acceptance publication date 17 March 2011

International Classifications

A61K 39/15 (2006.01) Medicinal preparations containing antigens or antibodies - Reoviridae, e.g. calf diarrhea virus

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

Event Publications

13 September 2007 PCT application entered the National Phase

  PCT publication WO2006/087205 Priority application(s): WO2006/087205

17 March 2011 Application Accepted

  Published as AU-B-2006215761

14 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006215776-Receptacle for the separation of tumor cells

2006215754-Light comprising an elongate light source and a light-influencing element